AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06204874 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency ablation
Description: See left.
Study NCT06204874 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham ablation
Description: See left.
Study NCT05033873 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Universal Exercise Unit Therapy (UEU)
Description: Standing, walk standing, half standing, kneel standing, half kneel standing, quadruped position, three point quadruped , alternative quadruped , transitions, walking all these will be done in Universal Exercise Unit with a standardized protocol regimen.
Study NCT05033873 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sling Exercise Therapt (SET)
Description: 1. The patient's bilateral knee joints/feet will be suspended by a rope belt, and then the patient's pelvis will be elevated and maintained in supine or lateral position, adding flexion and extension training to lower limb if permitted.~2. In supine or lateral position, with patient's head, trunk and pelvis fixed, the therapist will use appropriate elastic bands to assist patient's limbs to do passive-power assisted-power resistance training in all directions (bending, stretch, outreach, and adduction).~3. The patient's chest and abdomen will be suspended by a wide elastic band, positioned him-self in the prone position with the fulcrum of bilateral elbows and knees, and then the torso swayed in all directions, therapists could assist~4. Target elbow and wrist will be suspended, according to the patient's ability to do passive/active open and close chain movement
Study NCT05033873 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Routine Physical Therapy / Control Group
Description: Control group will receive routine physiotherapy with duration one hour including~* Active and passive joint movement~* Muscle strength training~* Bridging exercises~* Balance training in sitting and standing positions, according to the patients' functional state.~* Weight bearing exercises on affected Limbs
Study NCT05827432 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Field-cycling imaging (FCI)
Description: FCI scan
Study NCT05175638 — intervention group
Intervention type: GENETIC
Intervention: Gene Expression
Description: the expression of specific CNS enzyme (enolase), proinflammatory cytokines MIF and apoptotic marker caspase-3 in the umbilical blood of infants delivered for Covid positive mothers.
Study NCT05748496 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief behavioral sleep therapy, sleep hygiene education and mindfulness training
Description: Brief behavioral sleep therapy, sleep hygiene education and mindfulness training using breathing exercises and Yoga Nidra
Study NCT05491304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Single drug in non-severe group; combined with etoposide±ruxolitinib in severe group.
Study NCT05491304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Used in severe group combined with etoposide.
Study NCT05491304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Description: Single drug in non-severe group; combined with etoposide and dexamethasone in severe group.
Study NCT02238574 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: surgery
Description: excision or carbondioxide laser evaporation of the mucosal lesion of the oral cavity
Study NCT02238574 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: follow up
Description: Intensified outpatient follow up (16 visits in 5 years)
Study NCT02238574 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: follow up
Description: Intensified outpatient follow up (16 visits in 5 years)
Study NCT04788511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Semaglutide will be injected into a skin fold, in the stomach, thigh or upper arm once a week at the same day of the week (to the extent possible) throughout the trial.~Dose gradually escalated from 0.25 mg until target dose. The study will last for approximately 59 weeks.
Study NCT04788511 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (semaglutide)
Description: Placebo will be injected into a skin fold, in the stomach, thigh or upper arm once a week at the same day of the week (to the extent possible) throughout the trial.~The study will last for approximately 59 weeks.
Study NCT06367673 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: iPSC-NK cells
Description: iPSC-NK cells
Study NCT05898256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cadonilimab
Description: 10mg/kg administered intravenously (IV)
Study NCT05898256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: 1 g/m2, administered as an IV infusion within 30 minutes
Study NCT05898256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: 80 mg/m2, administered as an IV infusion over 4 hours
Study NCT04834349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hafnium Oxide-containing Nanoparticles NBTXR3
Description: Given IT
Study NCT04834349 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Proton Therapy
Description: Undergo IMPT
Study NCT04834349 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo IMRT
Study NCT04834349 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT04834349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04834349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT04834349 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy
Description: Undergo SBRT
Study NCT05614154 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: hypochlorous active substance
Description: Poviodin iyot
Study NCT05614154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: hypochlorous active substance
Description: Poviodin iyot
Study NCT06290674 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Extracorporeal Shockwave therapy
Description: 2000 shots, 120mJ pulse energy setting, 3 bar pressure, and 15 Hz for 15 minute per session.
Study NCT06290674 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Balanced low-calorie diet
Description: 1500 k/cal for 6 weeks
Study NCT06290674 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Balanced low-calorie diet
Description: 1500 k/cal for 6 weeks
Study NCT05063799 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pulmonary rehabilitation
Description: pulmonary rehabilitation programs
Study NCT05517837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986421
Description: Specified dose on specified days
Study NCT05517837 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Specified dose on specified days
Study NCT06407596 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high intensity laser
Description: 3 times per week, for 9 sessions
Study NCT06407596 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tens+us
Description: 5 times per week, total 15 sessions for 3 weeks
Study NCT06385431 — intervention group
Intervention type: OTHER
Intervention: observational study
Description: obeservational study with none intervention
Study NCT04270201 — intervention group
Intervention type: OTHER
Intervention: Saliva collection
Description: Saliva collection
Study NCT05367232 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ICP-033 tablet
Description: Administered orally, once a day, 28 days per cycle
Study NCT04771949 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Full periodontal chart
Description: A full periodontal chart will be carried out including all biometric periodontal variables: Probing Pocket Depth (PPD), Bleeding on Probing (BoP), presence of Plaque, recession (REC), Full Mouth Plaque Score (FMPS), Full Mouth Bleeding Score (FMBS), presence of furcation and mobility. Periodontal status, as assessed by the periodontal chart, will be evaluated following the New Classification of Periodontal and Peri implant diseases.
Study NCT04771949 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: After the periodontal chart, patients will be administered the italian version of 4 questionnaires regarding:~1. Adherence to Mediterranean Diet (Gnagnarella et al. 2018);~2. International Physical Activity Questionnaire (IPAQ) (Mannocci et al. 2010);~3. Pittsburgh Sleep Quality Index (PSQI) (Curcio et al. 2013);~4. Italian Perceived Stress Scale (Fossati, 2010).
Study NCT03548246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate
Description: Daily oral abiraterone acetate for 2 years. The dose will be specified based on pharmacodynamic data from Phase 1.
Study NCT03548246 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily placebo for 2 years.
Study NCT03548246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Description: Hydrocortisone will be administered at a starting dose of 7-9 mg/M2/d and adjusted as necessary based on 17-hydroxyprogesterone and ACTH levels.
Study NCT03548246 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Hydrocortisone
Description: Hydrocortisone will be administered at a starting dose of 7-9 mg/M2/d and adjusted as necessary based on 17-hydroxyprogesterone and ACTH levels.
Study NCT03548246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludrocortisone
Description: Fludrocortisone will be administered at the dose the subject was taking a study entry and adjusted as necessary to keep plasma renin in the high normal range.
Study NCT03548246 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Fludrocortisone
Description: Fludrocortisone will be administered at the dose the subject was taking a study entry and adjusted as necessary to keep plasma renin in the high normal range.
Study NCT05285930 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Bee venom phonophoresis
Description: phonophoresis with Bee Venom gel in form of a noncontact low-frequency pulsed ultrasound delivered through Bee Venom gel as a topical treatment at a distance of between 5 and 15 mm from the ulcer wound bed, and time was 10 minutes for each session in addition to conservative treatment of medical ulcer care. The performance of the ultrasound applicator was tested regularly before and after each patient exposure; each test included all relevant acoustic field parameters (pressure amplitude, frequency) and uniformity of the field distribution. This type of test of the acoustic output of the applicators was important to eliminate the possibility of any malfunctioning of the devices.
Study NCT05285930 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: low intensity ultrasound
Description: a noncontact low-frequency pulsed ultrasound delivered through plain gel only at a distance of between 5 and 15 mm from the ulcer wound bed, and time was 10 minutes for each session in addition to conservative treatment of medical ulcer care.
Study NCT04639141 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Synbiotic
Description: Prebiotic + Probiotic
Study NCT04639141 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Synbiotic
Description: Prebiotic + Probiotic
Study NCT04639141 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gut-directed Hypnotherapy
Description: Psychotherapy sessions
Study NCT05838846 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inhaled Milrinone
Description: Patients will receive 2 doses of inhaled milrinone at the following time points (after sternotomy and after aortic cross clamp off) at dosage of 50 mcg/kg by nebulization (21-23), inhaled milrinone will be administered through Aerogen solo with Pro-X controller - continuous mode- attached to ventilator circuit distal to viral/ bacterial heat and moisture exchange filter.
Study NCT05838846 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IV Milrinone
Description: Patients will receive intravenous milrinone - started after induction of anesthesia - infusion at dosage of 0.5 mcg/kg/min without loading dose (24), Pulmonary vascular resistance and systemic vascular resistance will be calculated at the same corresponding time points to group A.
Study NCT06254547 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Daily updated ranking on leaderboard
Description: The intervention will last for seven days. Participants will on day two through seven receive a group daily message using an internet-based messaging service and view a daily updated leaderboard ranking.~Leaderboards will demonstrate participant's ranking in their respective group, participant's (anonymized) name, cumulative point total, total case amount, and current level. Participant ranking will be based on the cumulative point total. All groups will have continual access to their personal score.~Participants will not receive further training encouragement to train in the app or interact with the research group beyond this, aside from technological aid.
Study NCT06254547 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Daily motivational message
Description: The intervention will last for seven days. Participants will on day two through seven receive a group daily message using an internet-based messaging service encouraging training.~Participants will not receive further training encouragement to train in the app or interact with the research group beyond this, aside from technological aid.
Study NCT06443554 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Health Management Intervention Program
Description: This study implemented a 12-week eye health management intervention program based on the Protection Motivation Theory (PMT). The intervention included eye health interventions conducted twice weekly at community health service locations.During the health management process, specialist doctors from higher-level comprehensive hospitals provided professional guidance, while community general practitioners took on a leading role. They provided personalized eye health management for patients under the guidance of the PMT theory. The intervention content included group education, individual guidance, experience sharing meetings, and traditional Chinese medicine appropriate technology, among other aspects.
Study NCT06443554 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Standard Treatment
Description: Each week, patients were subjected to standard treatment and follow-up procedures, including basic interventions, medication, and routine follow-up via phone or WeChat, during which general conditions were assessed.
Study NCT05663437 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Core stabilization exercises
Description: 6 core stabilization exercises including: dead bug, side lying, prone, bird dog, bridging, planks (1x10 reps for 15-30 secs each exercise) 3 alternative days a week, for 4 weeks.
Study NCT05663437 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core stabilization exercises + neural mobilization technique
Description: 6 core stabilization exercises including: dead bug, side lying, prone, bird dog, bridging, planks (1x10 reps for 15-30 secs each exercise) 3 alternative days a week, for 4 weeks.~Neural mobilization technique (SLR intervention for first 2 weeks and slider intervention for last 2 weeks).
Study NCT05636956 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education and Counseling Program
Description: Researches created an education and counseling program. In this context, patients receive an one hour education. Education program consist of face-to-face informing and teach-back method. At the end of the face-to-face informing, researchers give a comicbook about instructions of living with CIEDs as a written material. After discharge, researches follow-up patients with phone calls. In the context of phone calls researches continue to informing patients, remind related instructions for that time and answer questions of patients. Patients are allowed to reach reserarches any time if they have any concern or question. This program lasts for six months.
Study NCT05309343 — intervention group
Intervention type: DRUG
Intervention: Chinese patent medicine
Description: Shexiang Baoxin Pill, Tongxinluo Capsule, Tongmai Yangxin Pill, Xuefu Zhuyu Capsule, Qishen Yiqi Dropping Pill, etc.
Study NCT05163587 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: low GI composite flour
Description: low GI composite flour orally in chapati form (3times/day)
Study NCT05163587 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: low GI composite flour
Description: low GI composite flour orally in chapati form (3times/day)
Study NCT06494891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous Alcohol
Description: Participants will receive intravenous alcohol (6% ethanol v/v in saline; obtained from the Ronald Reagan UCLA Medical Center Investigational Drug Service) over the course of an alcohol challenge. During the challenge, participants will be administered alcohol designed to reach target BrACs of 20, 40, and 60 mg%, each over 15 min. After reaching the last target BrAC (0.06 g/dl) participants will complete a self-administration (SA) paradigm. Participants will be invited to work (button press) for alcohol according to a log-linear progressive ratio schedule.
Study NCT04989413 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral drops
Description: use of placebo for 12 weeks
Study NCT04989413 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cannabidiol + Cannabigerol + Tetrahydrocannabinol 133/66/4mg
Description: use of cannabidiol + canabigerol + thc for 12 weeks
Study NCT06159153 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Dynamic Ultrasonography assessment
Description: Ultrasound evaluation that will be compared with an MRI.
Study NCT05999357 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JDQ443
Description: JDQ443 tablets, orally administered
Study NCT04465708 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Homework, Organization, and Planning Skills
Description: HOPS is a 16-session, skills training program, provided individually to students in grades 6 through 8 who have OTMP skills deficits that contribute to academic difficulties. HOPS includes two parent consultations and one teacher consultation to promote generalization and maintenance of effects.
Study NCT05795036 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: mHealth 1
Description: Participants will use Fitbit device to self-monitor their physical activity in 8 weeks.
Study NCT05795036 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: mHealth 2
Description: Participants will use Fitbit device to self-monitor their physical activity in 8 weeks. In addition, they will receive daily motivational text message.
Study NCT05382845 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Manual pain provocation tests
Description: Validated and empirical pain provocation tests of the pelvic joints will be performed, both to exclude ongoing symptoms, and to diagnose one or several dysfunctions. The participants will be asked questions regarding previous symptoms, traumas, type of profession etc.
Study NCT05899426 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: motor learning based clinical pilates
Description: The exercises will be created as function and goal. At least one stimulus will be given during each exercise (visual, tactile, auditory or vestibular). 2 different levels were determined for 3 months of treatment, according to the months. As the level increased, the intensity of the exercise increased. In general, the exercise intensity was increased according to the against gravity and the decreasing in the support area.
Study NCT05899426 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physiotherapy
Description: This exercise program will include strengthening, stretching, posture exercises, balance and gait exercises. Aim is to improve muscle strength and prevent shortness of muscles. Also, balance and gait exercise aim to improve walking capacity.
Study NCT05717231 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: laughter yoga
Description: laughter yoga
Study NCT05088018 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cannabigerol
Description: Cannabigerol is a non-psychoactive cannabinoid obtained from the cannabis plant.
Study NCT05088018 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A placebo form of the same swallowable tablet with no cannabigerol
Study NCT04514666 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breath analysis
Description: The breath of patients undergoing liver or kidney transplant will be sampled and volatile organic compounds will be identified
Study NCT05544019 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SGR-1505
Description: SGR-1505 will be administered orally.
Study NCT04854187 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: N95 Mask/Indoor air purifier: Including sham
Description: Participants will be using indoor air purifier and N95 mask (control arm with sham filters). The effect will be studied on blood pressure and blood glucose levels.
Study NCT04854187 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: N95 Mask/Indoor air purifier: Including sham
Description: Participants will be using indoor air purifier and N95 mask (control arm with sham filters). The effect will be studied on blood pressure and blood glucose levels.